Literature DB >> 9460522

Performance evaluation of a large axial field-of-view PET scanner: SET-2400W.

T Fujiwara1, S Watanuki, S Yamamoto, M Miyake, S Seo, M Itoh, K Ishii, H Orihara, H Fukuda, T Satoh, K Kitamura, K Tanaka, S Takahashi.   

Abstract

The SET-2400W is a newly designed whole-body PET scanner with a large axial field of view (20 cm). Its physical performance was investigated and evaluated. The scanner consists of four rings of 112 BGO detector units (22.8 mm in-plane x 50 mm axial x 30 mm depth). Each detector unit has a 6 (in-plane) x 8 (axial) matrix of BGO crystals coupled to two dual photomultiplier tubes. They are arranged in 32 rings giving 63 two-dimensional image planes. Sensitivity for a 20-cm cylindrical phantom was 6.1 kcps/kBq/ml (224 kcps/microCi/ml) in the 2D clinical mode, and to 48.6 kcps/kBq/ml (1.8 Mcps/microCi/ml) in the 3D mode after scatter correction. In-plane spatial resolution was 3.9 mm FWHM at the center of the field-of-view, and 4.4 mm FWHM tangentially, and 5.4 mm FWHM radially at 100 mm from the center. Average axial resolution was 4.5 mm FWHM at the center and 5.8 mm FWHM at a radial position 100 mm from the center. Average scatter fraction was 8% for the 2D mode and 40% for the 3D mode. The maximum count rate was 230 kcps in the 2D mode and 350 kcps in the 3D mode. Clinical images demonstrate the utility of an enlarged axial field-of-view scanner in brain study and whole-body PET imaging.

Mesh:

Substances:

Year:  1997        PMID: 9460522     DOI: 10.1007/bf03165298

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  15 in total

1.  Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.

Authors:  Manabu Tashiro; Hideki Mochizuki; Yumiko Sakurada; Kenji Ishii; Keiichi Oda; Yuichi Kimura; Toru Sasaki; Kiichi Ishiwata; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  Development of a high-sensitivity BGO well counter for small animal PET studies.

Authors:  Seiichi Yamamoto; Hiroshi Watabe; Yasukazu Kanai; Tadashi Watabe; Masao Imaizumi; Eku Shimosegawa; Jun Hatazawa
Journal:  Radiol Phys Technol       Date:  2011-10-11

3.  Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.

Authors:  M Tagawa; M Kano; N Okamura; M Higuchi; M Matsuda; Y Mizuki; H Arai; R Iwata; T Fujii; S Komemushi; T Ido; M Itoh; H Sasaki; T Watanabe; K Yanai
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

4.  Brain activity following esophageal acid infusion using positron emission tomography.

Authors:  Shigeyuki Kobayashi; Yasuhiko Abe; Manabu Tashiro; Tomoyuki Koike; Katsunori Iijima; Akira Imatani; Shuichi Ohara; Satoshi Watanabe; Shin Fukudo; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

5.  Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine.

Authors:  N Okamura; K Yanai; M Higuchi; J Sakai; R Iwata; T Ido; H Sasaki; T Watanabe; M Itoh
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

6.  Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.

Authors:  Kenji Ishibashi; Yuko Saito; Shigeo Murayama; Kazutomi Kanemaru; Keiichi Oda; Kiichi Ishiwata; Hidehiro Mizusawa; Kenji Ishii
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

7.  Decrease in glucose metabolism in frontal cortex associated with deterioration of microstructure of corpus callosum measured by diffusion tensor imaging in healthy elderly.

Authors:  Kentaro Inoue; Hiroshi Ito; Shinya Uchida; Yasuyuki Taki; Shigeo Kinomura; Ichiro Tsuji; Shigeru Sato; Kaoru Horie; Ryuta Kawashima; Masatoshi Ito; Hiroshi Fukuda
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

8.  FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

Authors:  Kazuo Kubota; Jyunkichi Yokoyama; Keiichiro Yamaguchi; Shuichi Ono; Ahmad Qureshy; Masatoshi Itoh; Hiroshi Fukuda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

9.  Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.

Authors:  Manabu Tashiro; Xudong Duan; Motohisa Kato; Masayasu Miyake; Shoichi Watanuki; Yoichi Ishikawa; Yoshihito Funaki; Ren Iwata; Masatoshi Itoh; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2008-04-11       Impact factor: 4.335

10.  Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans.

Authors:  Miho Shidahara; Manabu Tashiro; Nobuyuki Okamura; Shozo Furumoto; Katsutoshi Furukawa; Shoichi Watanuki; Kotaro Hiraoka; Masayasu Miyake; Ren Iwata; Hajime Tamura; Hiroyuki Arai; Yukitsuka Kudo; Kazuhiko Yanai
Journal:  EJNMMI Res       Date:  2013-04-24       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.